Skip to content

Vaccine Social Media Randomized Intervention Trial

Randomized Intervention Trial to Evaluate a Vaccine Social Media Website

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01873040
Acronym
VSMRCT
Enrollment
1675
Registered
2013-06-07
Start date
2013-08-31
Completion date
2016-11-30
Last updated
2017-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Communicable Diseases

Keywords

Social Media, Vaccine, Immunization

Brief summary

This study will assess the effectiveness of social media website devoted to vaccines to change immunization knowledge, perceptions and behavior. If effective, this intervention will represent an innovative, low cost and broadly applicable resource to reduce parental vaccination concerns. The study has two hypothesis: 1. Parents receiving usual care plus social media website will demonstrate higher early childhood immunization rates to parents receiving either usual plus non interactive website or usual care only. 2. Parents receiving usual care plus social media website will demonstrate positive changes in knowledge, attitudes and beliefs supporting vaccination compared to parents receiving either usual care plus non-interactive website or usual care only.

Detailed description

Participants will be enrolled in the study, stratified based on hesitancy and randomly assigned to 1 of 3 study arms and followed for 1-2 years.

Interventions

BEHAVIORALSocial Media plus information pages

Participants will receive access to the study vaccine website information pages and social media feature including blogs, discussion forums, expert chats, and ask an expert.

BEHAVIORALVaccine Information Pages

Participants will receive access to the study vaccine website information pages.

Sponsors

Agency for Healthcare Research and Quality (AHRQ)
CollaboratorFED
Kaiser Permanente
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Women \>20 weeks Pregnant (including parents of children up to 1 year of age). * \>18 years of age

Exclusion criteria

* Non english speak * Do not intend to use Kaiser insurance for the child

Design outcomes

Primary

MeasureTime frameDescription
Days under-immunized2 yearsDays under-immunized is a metric to identify immunization delay. For each vaccine dose calculate the difference between when the vaccine dose was actually administered and when the vaccine dose should have been administered according to the Advisory Committee on Immunization Practices (ACIP) schedule. That difference is summed across all doses and vaccines for a total number of days under-immunized for each child. Total days under immunized was calculated 200 days after life or after enrollment. If someone had 0 days at that time they were considered up to date.

Secondary

MeasureTime frameDescription
Knowledge, Attitudes and Beliefs about immunizationsBaseline, Child age 3-5 months, Child age 12-15 monthsKnowledge, attitudes, and beliefs will be measured with a survey at up to 3 time points during the study: 1) Initial enrollment in the study, 2) child's ag=4-6 months and 3) child's age=11-13 months.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 6, 2026